EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE

Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD).Material and methods. 50 patients (34 men and 16 wo...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. N. Tolpygina, S. Y. Martsevich
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	: ischemic heart disease heart rate metoprolol succinate
Online Access:	https://www.rpcardio.online/jour/article/view/1156
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
by: J. V. Lukina, et al.
Published: (2015-12-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
by: M. V. Soura
Published: (2016-01-01)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?
by: E. V. Kuleshova
Published: (2016-01-01)

INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01)

Unfavorable influence of amlodipine combined with metoprolol on the short-term prognosis in hypertensive heart failure patients
by: Zu-qiu Liu, et al.
Published: (2025-08-01)

Fixed-dose combination of ivabradine and metoprolol in a patient with stable coronary artery disease: a case report
by: A. M. Shimkevich
Published: (2021-10-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Hot melt extrusion assisted additive manufacturing of mixed polymeric 3D printed metoprolol succinate extended-release tablets for controlled oral drug delivery
by: Shubham Ghatole, et al.
Published: (2025-06-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
by: T. S. Jahangirov, et al.
Published: (2001-10-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
by: V. E. Oleinikov, et al.
Published: (2015-12-01)

Ivabradine therapy effectiveness in patients with chronic heart failure, Functional Class III
by: S. G. Kanorskiy, et al.
Published: (2011-04-01)

Treatment optimisation in patients with functional Class II chronic heart failure and arterial hypertension
by: S. G. Kanorskyi, et al.
Published: (2012-04-01)

ANTIHYPERTENSIVE THERAPY EFFECTS ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH FUNCTIONAL CLASS I–II CHRONIC HEART FAILURE
by: S. G. Kanorskyi, et al.
Published: (2012-10-01)

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol
by: N. L. Afanasyeva, et al.
Published: (2005-02-01)

EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS
by: O. L. Barbarash, et al.
Published: (2016-01-01)

COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
by: A. A. Anderzhanova, et al.
Published: (2016-01-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
by: A. R. Kiselev, et al.
Published: (2016-01-01)

THE USAGE OF METOPROLOL TARTRATE IN ELDERLY AND OLD PATIENTS WITH CORONARY HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE
by: E. B. Nagaytseva, et al.
Published: (2003-06-01)

«MEMORIES OF FUTURE»: CHANGE IN VERAPAMIL SIGNIFICANCE IN THE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION
by: S. R. Gilyarevskiy
Published: (2015-09-01)

Metoprolol Use in Hypertensive Pregnancy Disorder – a Single-center Study
by: Buicu Corneliu-Florin, et al.
Published: (2025-03-01)

TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1)
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease
by: E. I. Tarlovskaya, et al.
Published: (2016-03-01)

EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
by: A. N. Meshkov
Published: (2016-01-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

Persistent Beta‐Blocker Therapy Reduces Long‐Term Mortality in Patients With Acute Ischemic Stroke With Elevated Heart Rates
by: Keon‐Joo Lee, et al.
Published: (2025-03-01)

Successful treatment of polymedicamentous poisoning with metoprolol, diltiazem and cilazapril
by: Radovanović Milan R., et al.
Published: (2009-01-01)

Isotherms and Thermodynamic Parameters of Metoprolol Drug Adsorption on the Prepared Mesoporous Silica
by: Manar A. Sachit, et al.
Published: (2024-03-01)

Thrombotic event prevention in patients with post-infarction chronic heart failure, as а part of complex therapy including various classes of beta -adrenoblockers
by: Yu. V. Larina, et al.
Published: (2008-12-01)

Investigation of Metoprolol Concentrations in Plasma Using Automated Sample Preparation and LC-MS/MS Detection
by: Ionel-Bogdan Cioroiu, et al.
Published: (2024-10-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

An eco-friendly bioanalytical RP-HPLC method coupled with fluorescence detection for simultaneous estimation of felodipine and metoprolol
by: Mariam Wasim Beniamin, et al.
Published: (2025-05-01)

ENDOTHELIAL DYSFUNCTION AND “OXIDATIVE STRESS” BY THE NONNSTABLE COURSE OF ISCHEMIC HEART DISEASE
by: A. E. Kratnov, et al.
Published: (2014-07-01)

Features of the arterial hypertension clinical course in patients with ischemic heart disease and atrial fibrillation.
by: M. I. Yalovenko, et al.
Published: (2019-01-01)

PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: A. L. Komarov, et al.
Published: (2016-01-01)

CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
by: V. E. Oleynikov, et al.
Published: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

PROTECTION OF BRAIN MITOCHONDRIA AGAINST MICRO STROKE-INDUCED INJURY: A STUDY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN EXPERIMENTAL MODEL USING TWO PHOTON LASER FLUORESCENT MICROSCOPY
by: R. A. Afzalov, et al.
Published: (2016-08-01)